This is not the most recent version of the article. View current version (17 JUN 2014)

Intervention Protocol

Creatine for Parkinson's disease

  1. Jin Wang1,
  2. Yousheng Xiao1,*,
  3. Shijian Chen1,
  4. Cai Zhong1,
  5. Man Luo1,
  6. Hongye Luo2

Editorial Group: Cochrane Movement Disorders Group

Published Online: 15 FEB 2012

DOI: 10.1002/14651858.CD009646


How to Cite

Wang J, Xiao Y, Chen S, Zhong C, Luo M, Luo H. Creatine for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009646. DOI: 10.1002/14651858.CD009646.

Author Information

  1. 1

    The First Affiliated Hospital, Guangxi Medical University, Department of Neurology, Nanning, Guangxi, China

  2. 2

    Guangxi Medical University, Department of Epidemiology & Statistics, Nanning, Guangxi, China

*Yousheng Xiao, Department of Neurology, The First Affiliated Hospital, Guangxi Medical University, No. 22, Shuang Yong Lu, Nanning, Guangxi, 530021, China. xys120@126.com.

Publication History

  1. Publication Status: New
  2. Published Online: 15 FEB 2012

SEARCH

This is not the most recent version of the article. View current version (17 JUN 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of creatine when used alone or as an adjuvant treatment for Parkinson's disease.